GANX

GAIN THERAPEUTICS INC

GANX·36269B105·US·Common Stock·Healthcare - Biotechnology

GANX (GAIN THERAPEUTICS INC) is held by 32 institutional investors as of Q2 2026. Largest holders: MARSHALL WACE, LLP ($3.9M), JONES FINANCIAL COMPANIES LLLP ($1.1M), VANGUARD CAPITAL MANAGEMENT LLC ($974,946). Net institutional sentiment: Mixed.

32
Holders
$11M
Total Value
60% (30)
Consensus
18 buying - 12 selling
13F: Insider & Congress: Updated regularly
GANX

Smart Money Verdict

View all
Loading verdict
Held by 32 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for GANX.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.9M(+8.7%)$3.9M0.0%-36.50%
29
Decreased
608,592(-3.6%)$1.1M0.0%-8.56%
0
Increased
480,269(+20.1%)$974,9460.0%-28.45%
20
Increased
453,501(+1.4%)$921,3720.0%-37.28%
17
Increased
274,957(+22.2%)$558,1630.0%-26.04%
20
Increased
231,534(+0.7%)$470,0140.0%-31.07%
24
Decreased
215,012(-2.5%)$436,4750.0%-23.89%
0
Unchanged
160,000$324,8000.0%-40.66%
0
Unchanged
157,537$319,8000.0%-35.13%
0
Increased
154,524(+520.6%)$313,6840.0%-14.89%
26
New
136,359$276,8090.0%-10.84%
32
Decreased
125,972(-9.8%)$255,7230.0%-7.64%
0
Increased
117,251(+12.5%)$238,0200.0%-38.37%
26
Decreased
97,013(-14.9%)$196,9360.0%-32.59%
0
Decreased
78,206(-81.9%)$158,7580.0%-38.27%
0
Increased
58,456(+96.8%)$118,6700.0%-25.39%
35
Decreased
55,628(-74.3%)$112,9250.0%-32.45%
0
New
55,294$112,2470.0%-10.84%
30
Unchanged
18,376$37,3030.0%-31.18%
0
New
17,174$34,8630.0%-10.84%
30

Showing 1-20 of 36

1 / 2
GANXGANXGAIN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used